Mingzhou Guo

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 34

Top Topics

Squamous Cell Carcinoma

Signaling Pathway

Dna Damage Response

Top Venues

Clinical epigenetics

Clinical and translational gastroenterology

Cancer biology & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaofeng Zhou, Ziyi Yan, Jinghan Hou, Lichen Zhang, Zhen Chen, Can Gao, Nor Hazwani Ahmad, Mingzhou Guo, Weilong Wang, Tao Han, Tingmin Chang, Xiaohong Kang, Lidong Wang, Yinming Liang, Xiumin Li
The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis. Oncogene 43 (7) (2024)
Qian Du, Meiying Zhang, Aiai Gao, Tao He, Mingzhou Guo
Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling. Cancer biology & therapy 25 (1) (2024)
Qian Du, Meiying Zhang, Aiai Gao, Tao He, Mingzhou Guo
Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling. Cancer biology & therapy 25 (1) (2024)
Meiying Zhang, Xiaoyun Li, James G Herman, Aiai Gao, Qian Wang, Yuanxin Yao, Fangfang Shen, Kunlun He, Mingzhou Guo
Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer. Clinical and translational gastroenterology 15 (3) (2024)
Qian Du, Meiying Zhang, Aiai Gao, Tao He, Mingzhou Guo
Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling. Cancer biology & therapy 25 (1) (2024)
Jing Zhou, Meiying Zhang, Aiai Gao, James G Herman, Mingzhou Guo
Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling. Epigenomics 16 (13) (2024)
Xiaofeng Zhou, Ziyi Yan, Jinghan Hou, Lichen Zhang, Zhen Chen, Can Gao, Nor Hazwani Ahmad, Mingzhou Guo, Weilong Wang, Tao Han, Tingmin Chang, Xiaohong Kang, Lidong Wang, Yinming Liang, Xiumin Li
The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis. Oncogene 43 (7) (2024)
Meiying Zhang, Xiaoyun Li, James G Herman, Aiai Gao, Qian Wang, Yuanxin Yao, Fangfang Shen, Kunlun He, Mingzhou Guo
Methylation of NRIP3 is a synthetic lethal marker for combined PI3K and ATR/ATM inhibitors in CRC. Clinical and translational gastroenterology (2024)
Xiaofeng Zhou, Ziyi Yan, Jinghan Hou, Lichen Zhang, Zhen Chen, Can Gao, Nor Hazwani Ahmad, Mingzhou Guo, Weilong Wang, Tao Han, Tingmin Chang, Xiaohong Kang, Lidong Wang, Yinming Liang, Xiumin Li
The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis. Oncogene 43 (7) (2024)
Meiying Zhang, Xiaoyun Li, James G Herman, Aiai Gao, Qian Wang, Yuanxin Yao, Fangfang Shen, Kunlun He, Mingzhou Guo
Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer. Clinical and translational gastroenterology 15 (3) (2024)
Qian Du, Meiying Zhang, Aiai Gao, Tao He, Mingzhou Guo
Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling. Cancer biology & therapy 25 (1) (2024)
Meiying Zhang, Xiaoyun Li, James G Herman, Aiai Gao, Qian Wang, Yuanxin Yao, Fangfang Shen, Kunlun He, Mingzhou Guo
Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer. Clinical and translational gastroenterology 15 (3) (2024)
Meiying Zhang, Xiaoyun Li, James G Herman, Aiai Gao, Qian Wang, Yuanxin Yao, Fangfang Shen, Kunlun He, Mingzhou Guo
Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer. Clinical and translational gastroenterology 15 (3) (2024)
Jing Zhou, Meiying Zhang, Aiai Gao, James G Herman, Mingzhou Guo
Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling. Epigenomics (2024)
Xiaofeng Zhou, Ziyi Yan, Jinghan Hou, Lichen Zhang, Zhen Chen, Can Gao, Nor Hazwani Ahmad, Mingzhou Guo, Weilong Wang, Tao Han, Tingmin Chang, Xiaohong Kang, Lidong Wang, Yinming Liang, Xiumin Li
The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis. Oncogene 43 (7) (2024)
Qian Du, Meiying Zhang, Aiai Gao, Tao He, Mingzhou Guo
Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling. Cancer biology & therapy 25 (1) (2024)
Xiaofeng Zhou, Ziyi Yan, Jinghan Hou, Lichen Zhang, Zhen Chen, Can Gao, Nor Hazwani Ahmad, Mingzhou Guo, Weilong Wang, Tao Han, Tingmin Chang, Xiaohong Kang, Lidong Wang, Yinming Liang, Xiumin Li
The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis. Oncogene 43 (7) (2024)
Xiaofeng Zhou, Ziyi Yan, Jinghan Hou, Lichen Zhang, Zhen Chen, Can Gao, Nor Hazwani Ahmad, Mingzhou Guo, Weilong Wang, Tao Han, Tingmin Chang, Xiaohong Kang, Lidong Wang, Yinming Liang, Xiumin Li
The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis. Oncogene (2024)
Qian Du, Meiying Zhang, Aiai Gao, Tao He, Mingzhou Guo
Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling. Cancer biology & therapy 25 (1) (2024)
Meiying Zhang, Xiaoyun Li, James G Herman, Aiai Gao, Qian Wang, Yuanxin Yao, Fangfang Shen, Kunlun He, Mingzhou Guo
Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer. Clinical and translational gastroenterology 15 (3) (2024)
Aiai Gao, Panpan Bai, Meiying Zhang, Yuanxin Yao, James G Herman, Mingzhou Guo
RASSF1A promotes ATM signaling and RASSF1A methylation is a synthetic lethal marker for ATR inhibitors. Epigenomics (2023)
Bo Zhou, Zhixin Wang, Qifeng Dou, Wenbin Li, Yangyang Li, Zhengqiang Yan, Peisheng Sun, Baosheng Zhao, Xiumin Li, Fangfang Shen, Bangjie Zhang, Mingzhou Guo
Long-term outcomes of esophageal and gastric cancer patients with cardiovascular and metabolic diseases: A two-center propensity score-matched cohort study. Journal of translational internal medicine 11 (3) (2023)
Wushuang Du, Aiai Gao, James G Herman, Lidong Wang, Lirong Zhang, Shunchang Jiao, Mingzhou Guo
Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer. Cancer science 112 (7) (2021)
Hongxia Li, Weili Yang, Meiying Zhang, Tao He, Fuyou Zhou, James G Herman, Liming Hu, Mingzhou Guo
Methylation of TMEM176A, a key ERK signaling regulator, is a novel synthetic lethality marker of ATM inhibitors in human lung cancer. Epigenomics 13 (17) (2021)
Yunlong Hu, Mingzhou Guo
Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer. Cancer science 111 (9) (2020)
Aiai Gao, Mingzhou Guo
Epigenetic based synthetic lethal strategies in human cancers. Biomarker research 8 (2020)
Yingge Liu, Meiying Zhang, Tao He, Weili Yang, Lidong Wang, Lirong Zhang, Mingzhou Guo
Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling. Clinical epigenetics 12 (1) (2020)
Zhen Sun, Songlei Xue, Meiying Zhang, Hui Xu, Xuming Hu, Shihao Chen, Yangyang Liu, Mingzhou Guo, Hengmi Cui
Aberrant NSUN2-mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma. Oncogene 39 (45) (2020)
Mingzhou Guo, Yaojun Peng, Aiai Gao, Chen Du, James G Herman
Epigenetic heterogeneity in cancer. Biomarker research 7 (2019)
Wenji Yan, Kongming Wu, James G Herman, Xiuduan Xu, Yunsheng Yang, Guanghai Dai, Mingzhou Guo
Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer. Clinical epigenetics 10 (2018)
Hongxia Li, Meiying Zhang, Enqiang Linghu, Fuyou Zhou, James G Herman, Liming Hu, Mingzhou Guo
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma. Clinical epigenetics 10 (1) (2018)
Yuzhu Wang, Tao He, James G Herman, Enqiang Linghu, Yunsheng Yang, François Fuks, Fuyou Zhou, Linjie Song, Mingzhou Guo
Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth. Clinical epigenetics 9 (2017)
Yulin Guo, Yaojun Peng, Dan Gao, Meiying Zhang, Weili Yang, Enqiang Linghu, James G Herman, François Fuks, Guanglong Dong, Mingzhou Guo
Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma. Clinical epigenetics 9 (2017)
Ruipan Zheng, Dan Gao, Tao He, Meiying Zhang, Xiaomei Zhang, Enqiang Linghu, Lixin Wei, Mingzhou Guo
Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis. Clinical epigenetics 9 (2017)